Morning Overview on MSN
A gene therapy injected straight into brain tumors just began dosing its first patients — a virus engineered to kill glioblastoma cells and spare the rest
Somewhere in an operating room this spring, a neurosurgeon did something that has never been done before: while removing a ...
Genetic sleuthing uncovers a rare case of cancer caused by a virus administered as part of a child’s treatment for a genetic ...
Doctors have linked a boy's tumor to a gene therapy, but say the rare risks need to be weighed against the profound benefits such medicines can offer.
UK and US trial sites open; first patient dosed with TGX-007, Trogenix’s proprietary dual-payload AAV gene therapy TGX-007 leverages Trogenix’s precision synthetic super-enhancer platform that ...
A sign at the Hospital of the University of Pennsylvania in Philadelphia. Researchers at the University of Pennsylvania believe they’re one step closer to finding a treatment that fights glioblastoma, ...
Biopsy specimen of a glioblastoma with prominent micovascular proliferation (formation of a mulitlayered "glomeruloid tuft", HE stain). (Jensflorian, CC BY-SA 3.0 , via Wikimedia Commons) From Philly ...
Morning Overview on MSN
A single molecule just shut down the gene behind the deadliest brain cancer in mice — and it did it without one harmful side effect
Glioblastoma kills roughly 10,000 Americans every year. Patients diagnosed with a recurrence after standard chemotherapy face a median survival measured in months, not years, and the drug they rely on ...
The CHOP's research team findings support the hypothesis that rare AAV integration can contribute to human oncogenesis, which ...
Summary: Researchers demonstrated that an experimental, systemic gene therapy can shield the central nervous system from the devastating cognitive decline and structural damage caused by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results